A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

NCT06945419 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Overweight
Obesity
Type 2 Diabetes

Interventions

DRUG: LY4086940
DRUG: Placebo
DRUG: LY4086940

Sponsor

Eli Lilly and Company